Original document(12 pages)  中文版
    The invention discloses a fluorocarbon emulsion auxiliary agent for increasing targeted area tissue energy deposition in HIFU treatment, which includes non-continuous phase constituted by filming material coating and continuous phase constituted by water-based medium, the non-continuous phase is dispersed in the continuous phase homogeneously, grain size of the non-continuous phase is 0.1-2um, the content of the film-forming material in the auxiliary agent is 0.1-100g/L, the core material is a liquid for generating liquid / gaseous phase change at 38-100 deg C, the content in the auxiliary agent is -200mg/L. The invention also discloses the use of the fluorocarbon emulsion auxiliary agent in HIFU treatment.
Application Number
申请号
200510000343 Application Date
申请日
2005.01.10
Title 名称 Fluorocarbonemulsion analog assistant for high-intensity focusing ultrasonic therapy and its uses
Publication Number
公开号
1803196 Publication Date
公开日
2006.07.19
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K49/22
Applicant(s) Name
申请人
Chongqing Haifu(HIFU) Technology Co., Ltd.
Address 地址 630000
Inventor(s) Name 发明人 Wang Zhibiao, Li Faqi, Xiao Ziwen, Xiao Yanbing, Liu Liping
Attorney & Agent 代理人 zhang tianshu

  
Ultra sonic wave therapeutic apparatus for gynaopathy and skin disease
Ultrasonic therapeatic apparatus preventing against early pregnancy
Supersonic quantitative diagnostic system and its echo image quantizing method
High-intensity focus supersonic tumor scanning therapy system
Endoscope type inserted supersonic cure probe
Ultrasonic therapeutical gun
Fluid discharging aerating breathing system
Combined device for ultrasonic diagnosis and treatment
Ultrasonic therapy head and ultrasonic therapy instrument containing same
Supersonic wave waveguide device
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.